3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Leukemia, Myeloid, Acute
3
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Neoplasms
2
Melanoma
2
Malignant Solid Neoplasm
2
Hematopoietic and Lymphatic System Neoplasm
2
Hematologic Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Renal Cell
2
COVID-19
2
Urologic Neoplasms
1
Urologic Diseases
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Teratoma
1
Stomatitis
1
Squamous Cell Carcinoma of Head and Neck
1
Spondylitis, Ankylosing
1
Renal Insufficiency, Chronic
1
Psoriasis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Peritoneal Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Mouth Neoplasms
1
Interventions
Specimen Handling
16
Magnetic Resonance Spectroscopy
15
Gemcitabine
14
pembrolizumab
11
Cisplatin
11
Mitomycin
7
Radiation
6
Fluorouracil
6
Cystoscopy
6
enfortumab vedotin
5
avelumab
5
Biopsy
5
dehydroftorafur
4
Transurethral Resection of Bladder
4
Radiotherapy
4
Platinum
4
Nivolumab
4
Mitozytrex
4
Carboplatin
4
1,2-diaminocyclohexaneplatinum II citrate
4
erdafitinib
3
durvalumab
3
cabozantinib
3
Immunoglobulin G
3
Disulfides
3
sapanisertib
2
olaparib
2
eribulin
2
atezolizumab
2
Surveys and Questionnaires
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Urinary Bladder Neoplasms
×
Practice Guidelines as Topic
×
30 days
×
Clear all
NCT07087860
2026-05-08
RECIPE-B1
Mayo Clinic
Phase 2
Recruiting
70 enrolled